Post

J.P. Morgan event in focus amid biotech M&A, obesity frenzy

Downvote
seekingalpha.com/news/4052827-jp-morgan-event-amid-biotech-ma-obesity-ai

The recent momentum in biotech deal-making, the rising interest in weight-loss drugs, and the popularity of artificial intelligence have all added significance to this year's J.P. Morgan Healthcare Conference, set to kick off on Monday in San Francisco, CA.
The four-day event, one of the premier investment conferences on the healthcare calendar, is expected to attract more…

This story from seekingalpha.com was posted on 2024-01-08 by @greenix.

Comments

The Entire Business World on a Single Page. Free to Use →